NGD-94-2

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameNGD-94-2
Drug Alias NameNGD-94-2
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D4 receptor antagonistsDopamine D2 receptor antagonists
TargetsDopamine D2 receptorDopamine D4 receptor
Therapy Area/IndicationsSchizophrenia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusDiscontinued (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesNeurogen Corp
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesSchering-Plough CorpNeurogen Corp
Active IndicationsN/A
Inactive IndicationsSchizophrenia

Other Information

ATC CodeN/A
Related LinksN/A